9th Circuit Reverses Class Denial In Generic Drug Price-Gouging Case

SAN FRANCISCO — Both named and unnamed plaintiffs in a drug-pricing class action allege the same injury from the same conduct, satisfying the typicality requirements for a class action, a Ninth...

Already a subscriber? Click here to view full article